Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/SCNI/Gross profit

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Gross profit 2024–2025

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) annual gross profit history from SEC filings — each fiscal year as reported.

-$2.7MFY2025 · since FY2024: -$580,000 → -$2.7M
2425
Fiscal yearValueYoY
FY2025-$2.7M-357.2%
FY2024-$580,000—

Source: SEC XBRL filings · For reference only · Not investment advice

More SCNI financial trends

SCNI RevenueSCNI Net incomeSCNI Net marginSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →